AUR vs. CLOV
AUR (Aurora Innovation, Inc.) and CLOV (Clover Health Investments, Corp.) are both stocks. AUR operates in Information Technology Services (Technology), while CLOV operates in Healthcare Plans (Healthcare). Over the past 5 years, AUR returned -8.23%/yr vs -12.37%/yr for CLOV. Their 0.40 correlation means their historical movements had little consistent relationship.
Performance
AUR vs. CLOV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AUR achieves a 67.97% return, which is significantly lower than CLOV's 77.45% return.
AUR
- 1D
- 3.37%
- 1M
- -2.71%
- 6M
- 53.57%
- YTD
- 67.97%
- 1Y
- 14.16%
- 3Y*
- 24.53%
- 5Y*
- -8.23%
- 10Y*
- —
- ALL TIME*
- -8.05%
CLOV
- 1D
- -3.92%
- 1M
- -20.72%
- 6M
- 86.16%
- YTD
- 77.45%
- 1Y
- 50.00%
- 3Y*
- 47.48%
- 5Y*
- -12.37%
- 10Y*
- —
- ALL TIME*
- -13.39%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $167.91M | $144.20M | $199.13M | |
| $16.28M | $21.81M | $31.68M |
AUR vs. CLOV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
AUR Aurora Innovation, Inc. | 67.97% | -39.05% | 44.16% | 261.16% | -89.25% | 12.60% |
CLOV Clover Health Investments, Corp. | 77.45% | -25.40% | 230.85% | 2.43% | -75.01% | -56.84% |
Correlation
The correlation between AUR and CLOV is 0.34, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.34 |
Correlation (3Y) Balances recent behavior with more history. | 0.33 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.41 |
Correlation (All Time) Calculated using the full available price history since May 10, 2021 | 0.40 |
Fundamentals
AUR:
$12.64B
CLOV:
$2.16B
AUR:
-$0.46
CLOV:
-$0.11
AUR:
2.50K
CLOV:
0.98
AUR:
6.53
CLOV:
6.42
AUR:
$5.00M
CLOV:
$2.21B
AUR:
$352.00M
CLOV:
$939.14M
AUR:
-$864.00M
CLOV:
-$55.21M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AUR vs. CLOV — Risk / Return Rank
AUR
CLOV
AUR vs. CLOV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Aurora Innovation, Inc. (AUR) and Clover Health Investments, Corp. (CLOV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AUR | CLOV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.46 | ||
| Sortino ratioReturn per unit of downside risk | -0.63 | ||
| Omega ratioGain probability vs. loss probability | 1.08 | 1.17 | -0.09 |
| Calmar ratioReturn relative to maximum drawdown | 0.26 | 0.80 | -0.54 |
| Martin ratioReturn relative to average drawdown | 0.41 | 1.50 | -1.08 |
Loading charts...
Drawdowns
AUR vs. CLOV - Drawdown Comparison
The maximum AUR drawdown since its inception was -93.34%, roughly equal to the maximum CLOV drawdown of -97.19%. Use the drawdown chart below to compare losses from any high point for AUR and CLOV.
Loading charts...
Drawdown Indicators
| AUR | CLOV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.34% | -97.19% | +3.85% |
Max Drawdown (1Y)Largest decline over 1 year | -42.53% | -55.50% | +12.97% |
Max Drawdown (3Y)Largest decline over 3 years | -63.00% | -64.73% | +1.73% |
Max Drawdown (5Y)Largest decline over 5 years | -93.34% | -94.24% | +0.90% |
Current DrawdownCurrent decline from peak | -62.30% | -81.17% | +18.87% |
Average DrawdownAverage peak-to-trough decline | -67.28% | -76.63% | +9.35% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 26.66% | 29.67% | -3.01% |
Volatility
AUR vs. CLOV - Volatility Comparison
Aurora Innovation, Inc. (AUR) has a higher volatility of 18.94% compared to Clover Health Investments, Corp. (CLOV) at 17.57%. This indicates that AUR's price experiences larger fluctuations and is considered to be riskier than CLOV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AUR | CLOV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.94% | 17.57% | +1.37% |
Volatility (6M)Calculated over the trailing 6-month period | 50.04% | 43.33% | +6.71% |
Volatility (1Y)Calculated over the trailing 1-year period | 63.00% | 70.03% | -7.03% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 91.18% | 76.63% | +14.55% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 89.15% | 85.26% | +3.89% |
Dividends
AUR vs. CLOV - Dividend Comparison
Neither AUR nor CLOV has paid dividends to shareholders.
Financials
AUR vs. CLOV - Financials Comparison
This section allows you to compare key financial metrics between Aurora Innovation, Inc. and Clover Health Investments, Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
AUR and CLOV have a correlation of 0.34, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AUR has higher volatility (18.94%) compared to CLOV (17.57%). In terms of maximum drawdown, AUR dropped -93.34% vs CLOV's -97.19%.
CLOV currently has the higher Sharpe Ratio (0.64 vs 0.18), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AUR and CLOV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer